Abstract
Adding Romidepsin to CHOEP in First Line Treatment of Peripheral T-Cell Lymphomas Does Not Improve the Response Rate: Final Analysis of Phase II PTCL13 Study
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have